What Researchers Did
Researchers compared 7 liver donors who received hyperbaric oxygen treatment, starting 3 days after surgery, with 7 donors who did not, after they gave part of their liver for a living donor transplant.
What They Found
In a small study of 14 living liver donors, the 7 who received hyperbaric oxygen treatment had less wound numbness at 28 days after surgery and a higher liver regeneration rate at 4 weeks than the 7 who did not. Wound numbness on day 28 was reported in 86% (6 of 7) of the control group and 29% (2 of 7) of the hyperbaric oxygen group (p less than 0.05). Hospital stay was similar, at 14.4 days in the control group and 14.6 days in the hyperbaric oxygen group (no significant difference). On day 14, the treated group had lower AST and higher PT%. Total bilirubin was lower on days 14 and 28, and albumin was higher on days 7, 10 and 28 (all p less than 0.05). Whole liver, graft and remnant liver volumes did not differ significantly between the groups.
What This Means for Canadian Patients
This abstract looked at people who donate part of their liver to another person. In this small group, those who received hyperbaric oxygen treatment after surgery had less wound numbness and better liver test results at some time points, but the abstract reports no shorter hospital stay. The authors state that the treatment seems very useful in this setting, but the abstract does not give the pressure or number of sessions, so it cannot guide treatment decisions on its own.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study included only 14 donors, 7 per group, and the abstract does not describe how donors were assigned to groups or give the treatment pressure or number of sessions, so the findings are preliminary.